Rooted in Research and Pure Science
At QR678, research and technology are at the core of everything we do. Our science-backed approach to hair loss is driven by extensive clinical studies, cutting-edge biotechnology, and a commitment to developing proven, non-surgical solutions. We continue to push the boundaries of hair science, ensuring our treatments deliver real, lasting results for patients worldwide.
Backed by Clinical Research
- Hair pull test negative in 88% of people in 8 sessions.
- Global assessment score jumped from 6 to 8 between the fourth and eighth sessions
- Terminal hair count, vellus hair count, and hair density saw huge improvements by session eight
- Patients gave themselves a higher satisfaction score—confidence restored!
- Long-term follow-up? No side effects, just great results
- QR678 Neo—a game-changing, safe, and effective solution for androgenetic alopecia and female pattern hair loss
QR678®️ & QR678 Neo®️ Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study
Current treatment modalities are limited in their approach and success for hair loss. QR678®️ & QR 678 Neo®️ are new formulations, consisting of a combination of growth factors and peptides. Thi..
Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth
Research has shown the efficacy of hair growth factors in hair regrowth. We describe the intradermal injections of a recombinant, bioengineered hair formulation, containing growt…
Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo®️ hair growth factor formulation
A phase-IV, open-label, single-arm multi-ethnicity clinical trial.
QR678®️ & QR678 Neo®️ Vs PRP—A randomized, comparative, prospective study
Hair plays a significant role in shaping the appearance of an individual. Loss of hair can lead to serious effects on social esteem of an individual. The most common cause of hair loss is…
Comparison of QR678®️ & QR678 Neo®️ as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride..
in the treatment of male androgenetic alopecia—Which is better?
Effectiveness of QR678®️ and QR678 Neo®️ with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment
of alopecia areata –A randomized, comparative, prospective study
Evaluation of efficacy of QR678®️ and QR678®️ Neo hair growth factor formulation in the treatment of persistent chemotherapy-induced
alopecia caused due to cytotoxic chemotherapy—A prospective pilot study
Evaluation of efficacy of QR678®️ and QR678 Neo®️ hair growth factor formulation for the treatment of female pattern alopecia in patients
with PCOS—A prospective study
Efficacy of QR678 Neo®️ hair growth factor formulation for the treatment of hair loss in Covid-19-induced persistent Telogen Effluvium -A
A prospective, clinical, single-blind study
A newer approach in the treatment of seborrheic dermatitis with QR678®️ and QR678 Neo®️—A prospective pilot study
Seborrheic dermatitis is a skin condition that mainly affects the scalp causing scaly patches, inflamed skin and stubborn dandruff. It usually affects oily areas of the body.
Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo®️ hair regrowth…
for the treatment of Androgenetic Alopecia—A prospective study
Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo®️ hair regrowth formulation in the treatme..
in the treatment of androgenetic alopecia
The iceberg phenomenon of alopecia associated public health ramifications on the quality of life among adults in India
Psychosocial implications and effect on the quality of life of individuals due to alopecia are underestimated. This article aims at highlighting its public health ramifications by assessing.
Disclaimer: QR678 Neo® is not a drug. Studies shared for academic reference only.
Are you a Doctor Interested in Collaborating with us for Research?
Disclaimer: QR678 Neo® is not a drug. Studies shared for academic reference only.